tiprankstipranks
Trending News
More News >
American Oncology Network (AONC)
OTHER OTC:AONC
US Market

American Oncology Network (AONC) Ratios

Compare
42 Followers

American Oncology Network Ratios

AONC's free cash flow for Q4 2024 was $0.09. For the 2024 fiscal year, AONC's free cash flow was decreased by $ and operating cash flow was
lt;0.01. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.53 1.53 1.64 1.72 1.75
Quick Ratio
1.25 1.25 1.38 1.46 1.46
Cash Ratio
0.29 0.29 0.17 0.19 0.23
Solvency Ratio
0.03 0.04 0.04 0.07 0.27
Operating Cash Flow Ratio
-0.07 -0.02 -0.11 -0.05 -0.22
Short-Term Operating Cash Flow Coverage
-4.31 -1.32 -2.30 -0.71 0.00
Net Current Asset Value
$ -30.85M$ -30.85M$ -25.94M$ -22.19M$ 186.02M
Leverage Ratios
Debt-to-Assets Ratio
0.31 0.31 0.34 0.39 0.26
Debt-to-Equity Ratio
7.85 7.85 -0.79 2.05 0.20
Debt-to-Capital Ratio
0.89 0.89 -3.84 0.67 0.17
Long-Term Debt-to-Capital Ratio
0.82 0.82 -0.99 0.56 0.17
Financial Leverage Ratio
25.06 25.06 -2.32 5.26 0.79
Debt Service Coverage Ratio
2.05 -0.06 -2.78 1.77 5.21
Interest Coverage Ratio
2.84 -2.47 -7.66 1.63 0.64
Debt to Market Cap
0.26 1.31 2.24 0.21 0.16
Interest Debt Per Share
11.18 11.26 20.15 3.13 1.56
Net Debt to EBITDA
5.88 46.57 -2.54 4.34 4.63
Profitability Margins
Gross Profit Margin
8.23%6.70%6.47%8.30%8.26%
EBIT Margin
0.44%-1.00%-4.38%0.52%0.19%
EBITDA Margin
1.50%0.10%-3.08%2.01%0.83%
Operating Profit Margin
1.02%-0.99%-3.84%0.48%0.10%
Pretax Profit Margin
0.08%-1.39%-4.89%0.23%0.04%
Net Profit Margin
0.03%-0.23%-0.43%0.23%-0.01%
Continuous Operations Profit Margin
0.12%-1.53%-4.92%0.23%-0.01%
Net Income Per EBT
31.95%16.24%8.87%100.00%-29.58%
EBT Per EBIT
7.87%140.34%127.17%46.51%38.97%
Return on Assets (ROA)
0.05%-0.84%-1.48%0.79%-0.04%
Return on Equity (ROE)
-2.46%-21.17%3.43%4.17%-0.03%
Return on Capital Employed (ROCE)
3.87%-6.88%-23.93%3.00%0.71%
Return on Invested Capital (ROIC)
3.70%-6.56%-22.22%2.72%-0.21%
Return on Tangible Assets
0.05%-0.87%-1.48%0.80%-0.04%
Earnings Yield
0.15%-5.72%-14.05%0.62%-0.03%
Efficiency Ratios
Receivables Turnover
5.07 9.28 7.75 6.92 6.83
Payables Turnover
5.17 9.62 9.37 9.90 9.32
Inventory Turnover
14.53 27.04 26.84 28.90 25.07
Fixed Asset Turnover
9.75 17.86 15.27 15.19 28.91
Asset Turnover
2.04 3.74 3.42 3.52 3.80
Working Capital Turnover Ratio
10.34 15.75 12.19 12.10 21.22
Cash Conversion Cycle
26.48 14.87 21.74 28.49 28.81
Days of Sales Outstanding
72.01 39.34 47.09 52.73 53.42
Days of Inventory Outstanding
25.12 13.50 13.60 12.63 14.56
Days of Payables Outstanding
70.65 37.96 38.94 36.87 39.17
Operating Cycle
97.13 52.84 60.69 65.36 67.97
Cash Flow Ratios
Operating Cash Flow Per Share
-1.20 -0.36 -2.71 -0.16 -0.63
Free Cash Flow Per Share
-2.14 -1.89 -4.55 -0.34 -0.83
CapEx Per Share
0.95 1.53 1.84 0.17 0.20
Free Cash Flow to Operating Cash Flow
1.79 5.24 1.68 2.06 1.32
Dividend Paid and CapEx Coverage Ratio
-1.26 -0.24 -1.48 -0.94 -3.16
Capital Expenditure Coverage Ratio
-1.26 -0.24 -1.48 -0.94 -3.16
Operating Cash Flow Coverage Ratio
-0.11 -0.03 -0.14 -0.05 -0.41
Operating Cash Flow to Sales Ratio
-0.02 >-0.01 -0.01 >-0.01 -0.03
Free Cash Flow Yield
-8.24%-37.31%-77.07%-3.34%-8.53%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
655.43 -17.47 -7.12 161.82 -3.87K
Price-to-Sales (P/S) Ratio
0.37 0.04 0.03 0.36 0.43
Price-to-Book (P/B) Ratio
8.62 3.70 -0.24 6.76 1.30
Price-to-Free Cash Flow (P/FCF) Ratio
-12.13 -2.68 -1.30 -29.98 -11.73
Price-to-Operating Cash Flow Ratio
-10.02 -14.04 -2.18 -61.76 -15.43
Price-to-Earnings Growth (PEG) Ratio
17.68 0.35 <0.01 -0.06 38.58
Price-to-Fair Value
8.62 3.70 -0.24 6.76 1.30
Enterprise Value Multiple
30.27 84.81 -3.54 22.49 56.39
Enterprise Value
435.50M 153.93M 139.23M 519.17M 442.80M
EV to EBITDA
30.27 84.81 -3.54 22.49 56.39
EV to Sales
0.45 0.09 0.11 0.45 0.47
EV to Free Cash Flow
-15.05 -5.94 -4.58 -37.14 -12.78
EV to Operating Cash Flow
-26.96 -31.14 -7.68 -76.53 -16.81
Tangible Book Value Per Share
7.01 6.90 10.39 1.46 5.40
Shareholders’ Equity Per Share
1.39 1.37 -24.19 1.49 7.50
Tax and Other Ratios
Effective Tax Rate
-0.46 -0.10 >-0.01 0.00 1.30
Revenue Per Share
71.24 128.27 191.32 27.58 22.64
Net Income Per Share
0.02 -0.29 -0.83 0.06 >-0.01
Tax Burden
0.32 0.16 0.09 1.00 -0.30
Interest Burden
0.18 1.39 1.11 0.43 0.20
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.07 0.08 0.08 0.08 0.08
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 0.00 <0.01
Income Quality
-12.09 0.18 0.29 -2.62 250.84
Currency in USD